Moberg Pharma Expands Cross-Border E-Commerce Channels to Enter China Market
Moberg Pharma has reached an agreement with Karo Healthcare to utilize cross-border e-commerce channels to introduce the antifungal drug MOB-015 into the Chinese market as part of its global expansion strategy aimed at achieving rapid market access.
What are the key facts?
- 1Entering China through cross-border e-commerce
- 2Expanding cooperation with Karo Healthcare
- 3Product is the antifungal drug MOB-015
What happened?
Moberg Pharma is expanding its cooperation with Karo Healthcare to introduce the antifungal drug MOB-015 into China through cross-border e-commerce channels. This collaboration aims to utilize the flexibility of cross-border e-commerce for expedited market entry as a first step towards long-term market penetration in China.
What does this mean for cross-border sellers?
Cross-border e-commerce has become the preferred low-barrier testing channel for pharmaceutical and health brands entering the Chinese market.